Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Biopharmaceutical Excipients market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Biopharmaceutical Excipients market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Biopharmaceutical Excipients market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Biopharmaceutical Excipients products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Biopharmaceutical Excipients products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Biopharmaceutical Excipients market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Biopharmaceutical Excipients development has been the leading industry trend of Biopharmaceutical Excipients market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Biopharmaceutical Excipients Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Solubilizers& Surfactants/Emulsifiers, Polyols, Carbohydrates, Other |
| By Application Outlook |
Biopharmaceutical Downstream, Biopharmaceutical Upstream, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
BASF SE, ABITEC Corp, Colorcon, Inc, DFE Pharma, Meggle AG, Pharmonix Biological, Roquette, Sigachi Industries, Signet Chemical Corporation, Spectrum Chemical Manufacturing Corp, SPI Pharma |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- BASF SE
- ABITEC Corp
- Colorcon
- Inc
- DFE Pharma
- Meggle AG
- Pharmonix Biological
- Roquette
- Sigachi Industries
- Signet Chemical Corporation
- Spectrum Chemical Manufacturing Corp
- SPI Pharma
Biopharmaceutical Excipients Market, By Type
- Solubilizers& Surfactants/Emulsifiers
- Polyols
- Carbohydrates
- Other
Biopharmaceutical Excipients Market, By Application
- Biopharmaceutical Downstream
- Biopharmaceutical Upstream
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Biopharmaceutical Excipients Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biopharmaceutical Excipients Market Size Growth Rate by Type
1.4.2 Solubilizers& Surfactants/Emulsifiers
1.4.3 Polyols
1.4.4 Carbohydrates
1.4.5 Other
1.5 Market by Application
1.5.1 Global Biopharmaceutical Excipients Market Size Growth Rate by Application
1.5.2 Biopharmaceutical Downstream
1.5.3 Biopharmaceutical Upstream
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biopharmaceutical Excipients Market Size
2.1.1 Global Biopharmaceutical Excipients Revenue 2017-2027
2.1.2 Global Biopharmaceutical Excipients Sales 2017-2027
2.2 Biopharmaceutical Excipients Growth Rate by Regions
2.2.1 Global Biopharmaceutical Excipients Sales by Regions
2.2.2 Global Biopharmaceutical Excipients Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Biopharmaceutical Excipients Sales by Manufacturers
3.1.1 Biopharmaceutical Excipients Sales by Manufacturers
3.1.2 Biopharmaceutical Excipients Sales Market Share by Manufacturers
3.2 Biopharmaceutical Excipients Revenue by Manufacturers
3.2.1 Biopharmaceutical Excipients Revenue by Manufacturers (2017-2020)
3.2.2 Biopharmaceutical Excipients Revenue Share by Manufacturers (2017-2020)
3.3 Biopharmaceutical Excipients Price by Manufacturers
3.4 Biopharmaceutical Excipients Manufacturing Base Distribution, Product Types
3.4.1 Biopharmaceutical Excipients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biopharmaceutical Excipients Product Type
3.4.3 Date of International Manufacturers Enter into Biopharmaceutical Excipients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Biopharmaceutical Excipients Sales by Type
4.2 Global Biopharmaceutical Excipients Revenue by Type
4.3 Biopharmaceutical Excipients Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Biopharmaceutical Excipients Breakdown Data by Application
6 North America
6.1 North America Biopharmaceutical Excipients by Country
6.1.1 North America Biopharmaceutical Excipients Sales by Country
6.1.2 North America Biopharmaceutical Excipients Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biopharmaceutical Excipients by Type
6.3 North America Biopharmaceutical Excipients by Application
7 Europe
7.1 Europe Biopharmaceutical Excipients by Country
7.1.1 Europe Biopharmaceutical Excipients Sales by Country
7.1.2 Europe Biopharmaceutical Excipients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biopharmaceutical Excipients by Type
7.3 Europe Biopharmaceutical Excipients by Application
8 Asia Pacific
8.1 Asia Pacific Biopharmaceutical Excipients by Country
8.1.1 Asia Pacific Biopharmaceutical Excipients Sales by Country
8.1.2 Asia Pacific Biopharmaceutical Excipients Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biopharmaceutical Excipients by Type
8.3 Asia Pacific Biopharmaceutical Excipients by Application
9 Central & South America
9.1 Central & South America Biopharmaceutical Excipients by Country
9.1.1 Central & South America Biopharmaceutical Excipients Sales by Country
9.1.2 Central & South America Biopharmaceutical Excipients Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Biopharmaceutical Excipients by Type
9.3 Central & South America Biopharmaceutical Excipients by Application
10 Middle East and Africa
10.1 Middle East and Africa Biopharmaceutical Excipients by Country
10.1.1 Middle East and Africa Biopharmaceutical Excipients Sales by Country
10.1.2 Middle East and Africa Biopharmaceutical Excipients Revenue by Country
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biopharmaceutical Excipients by Type
10.3 Middle East and Africa Biopharmaceutical Excipients by Application
11 Company Profiles
11.1 BASF SE
11.1.1 BASF SE Company Details
11.1.2 Company Business Overview
11.1.3 BASF SE Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.1.4 BASF SE Biopharmaceutical Excipients Products Offered
11.1.5 BASF SE Recent Development
11.2 ABITEC Corp
11.2.1 ABITEC Corp Company Details
11.2.2 Company Business Overview
11.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.2.4 ABITEC Corp Biopharmaceutical Excipients Products Offered
11.2.5 ABITEC Corp Recent Development
11.3 Colorcon, Inc
11.3.1 Colorcon, Inc Company Details
11.3.2 Company Business Overview
11.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Colorcon, Inc Biopharmaceutical Excipients Products Offered
11.3.5 Colorcon, Inc Recent Development
11.4 DFE Pharma
11.4.1 DFE Pharma Company Details
11.4.2 Company Business Overview
11.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.4.4 DFE Pharma Biopharmaceutical Excipients Products Offered
11.4.5 DFE Pharma Recent Development
11.5 Meggle AG
11.5.1 Meggle AG Company Details
11.5.2 Company Business Overview
11.5.3 Meggle AG Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Meggle AG Biopharmaceutical Excipients Products Offered
11.5.5 Meggle AG Recent Development
11.6 Pharmonix Biological
11.6.1 Pharmonix Biological Company Details
11.6.2 Company Business Overview
11.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Pharmonix Biological Biopharmaceutical Excipients Products Offered
11.6.5 Pharmonix Biological Recent Development
11.7 Roquette
11.7.1 Roquette Company Details
11.7.2 Company Business Overview
11.7.3 Roquette Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Roquette Biopharmaceutical Excipients Products Offered
11.7.5 Roquette Recent Development
11.8 Sigachi Industries
11.8.1 Sigachi Industries Company Details
11.8.2 Company Business Overview
11.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Sigachi Industries Biopharmaceutical Excipients Products Offered
11.8.5 Sigachi Industries Recent Development
11.9 Signet Chemical Corporation
11.9.1 Signet Chemical Corporation Company Details
11.9.2 Company Business Overview
11.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Signet Chemical Corporation Biopharmaceutical Excipients Products Offered
11.9.5 Signet Chemical Corporation Recent Development
11.10 Spectrum Chemical Manufacturing Corp
11.10.1 Spectrum Chemical Manufacturing Corp Company Details
11.10.2 Company Business Overview
11.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Products Offered
11.10.5 Spectrum Chemical Manufacturing Corp Recent Development
11.11 SPI Pharma
12 Future Forecast
12.1 Biopharmaceutical Excipients Market Forecast by Regions
12.1.1 Global Biopharmaceutical Excipients Sales Forecast by Regions 2019-2025
12.1.2 Global Biopharmaceutical Excipients Revenue Forecast by Regions 2019-2025
12.2 Biopharmaceutical Excipients Market Forecast by Type
12.2.1 Global Biopharmaceutical Excipients Sales Forecast by Type 2019-2025
12.2.2 Global Biopharmaceutical Excipients Revenue Forecast by Type 2019-2025
12.3 Biopharmaceutical Excipients Market Forecast by Application
12.4 North America Biopharmaceutical Excipients Forecast
12.5 Europe Biopharmaceutical Excipients Forecast
12.6 Asia Pacific Biopharmaceutical Excipients Forecast
12.7 Central & South America Biopharmaceutical Excipients Forecast
12.8 Middle East and Africa Biopharmaceutical Excipients Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biopharmaceutical Excipients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
